Rense.com



US Not Ready For Coming
Alzheimer's Epidemic
By Anne Harding
6-12-1

NEW YORK (Reuters Health) - The US healthcare system is not ready for the epidemic of Alzheimer's disease that will hit in the next decade as baby boomers age, experts warn.
 
 
"The boomers are going to be the healthiest [group] of people ever to hit their 70s and 80s," Dr. Steven T. DeKosky, director of the Alzheimer's Disease Research Center in Pittsburgh, Pennsylvania, said here Thursday at a briefing sponsored by the American Medical Association. Ironically, this will mean more and more people will live long enough to get Alzheimer's.
 
 
There are currently 34.8 million Americans 65 years and older, 4.3 million of whom are 85 or older. Dementia strikes 3% of people aged 65 to 74, 19% of those 75 to 84, and up to 47% of people 85 and older. The number of people with Alzheimer's is expected to triple over the next 30 to 40 years.
 
 
"This disease would break Medicare and Medicaid all by itself," DeKosky said. So, he added, strategies for diagnosing Alzheimer's early and treating or even preventing the disease are urgently needed. Delaying the disease course by 5 years could cut its prevalence in half, he noted, and delaying it by 10 years could potentially wipe it out.
 
 
But the current pace of research will not keep up with demand, according to DeKosky. Studies of preventive therapies currently under way will begin producing results in 2005. DeKosky recommends that several parallel trials of potential therapies be launched as soon as possible.
 
 
Training the immune system to sweep up amyloid plaques, the abnormal protein fragments that collect in the brains of Alzheimer's patients, has been found to be effective in mice. Preliminary trials in humans have found this approach is safe. Other promising avenues include drugs called neurotrophic factors, which prevent nerve cell death, and drugs that prevent the formation of fibrillary tangles in the brain, DeKosky said.
 
 
But effective treatments are available today, Dr. Rachelle S. Doody of the Alzheimer's Disease Research Center at Baylor College of Medicine in Houston, Texas, emphasized.
 
 
Drugs called cholinesterase inhibitors can delay the progress of Alzheimer's, she explained, and vitamin E has been shown to delay the loss of function. Therapy with anti-inflammatory medications and other antioxidants also has potential.
 
 
"The treatments we have now do more than we ever thought they would do," she said. But fewer than half of patients with Alzheimer's are ever offered such treatment, she pointed out.
 
 
And while therapy is currently offered only after patients have established disease, Doody said, experts are now able to recognize a condition called mild cognitive impairment (MCI) that represents, for many, the early stages of Alzheimer's.
 
 
Among people with MCI, 15% will develop Alzheimer's each year. Research is under way to see if treating these individuals with certain medications will delay or prevent this progression.
 
 
Effective treatment is also available for Alzheimer's symptoms. Psychosis can, in some patients, be treated with antipsychotic drugs, Doody noted. And antidepressants may help some Alzheimer's patients. Incontinence--a leading reason for institutionalization--can often be managed by scheduling bathroom times and using other non-drug approaches.
 
 
Soon, Doody said, it will be possible to manage Alzheimer's in the same way that heart disease is treated--by recognizing genetic and environmental risk factors and modifying these risk factors.
 
 
But DeKosky noted that while we have standard ways to determine a person's heart disease risk--such as blood pressure--there is still no simple, cheap test for Alzheimer's risk.
 
 
Copyright © 2001 Reuters Limited. All rights reserved.
 
 
 
Comment
 
From Gayle
leaflady@leaflady.org
6-13-1
 
Hi, Jeff,
 
Reading through this article it was interesting to me to note that there is no focus on prevention. There is no focus on finding the cause either.
 
I was interested in the fact that the researchers find a great benefit from vitamin E, yet our government is pushing to limit access to therapeutic doses of this beneficial vitamin under Codex. Of course there is little money for the pharmaceutical interests in treating with vitamins ( i.e., orthomolecular treatments).
 
The vitamin E issue also interests me from the perspective of another article you have up on the relationship between air pollution and heart attack. Vitamin E is exceptional for the healthy heart, and healthy lungs. You don't see much effort to get the air cleaned up, and the current president seems to be heading backwards with the policy to stall under the guise that "the economy cannot afford to clean up the air". So it goes.
 
Now for starter's, fluoridated water impedes thyroid function. At least 30% to 67% of all people with the Alzheimer's diagnosis, depending on which study you accept, show undiagnosed thyroid malfunction.
 
Most Alzheimer's patients are placed on Haldol, a wonderful psychotropic drug that is based in fluoride, and enjoys a delightful side effect called Tardive Dyskinesia.
 
Needless to say there is big money in Alzheimer's treatment, and the drugs that go along with the warehousing of our older citizens.
 
Many years ago, a study done at Norristown (PA) State Hospital, geriatric unit, found that malnutrition was more a cause of the aberrant behavior of the patients, than actual psychosis. Malnutrition, of course, can lead to diminished B complex vitamin intake and absorption, and dis-orders like Beri-Beri. Beri-Beri is a B vitamin (a brain and nervous system nutrient) deficiency with all the signs and symptoms of - you guessed it - psychoses and dementia.
 
Thanks again for letting me throw in my two cents,
                                                



MainPage
http://www.rense.com


This Site Served by TheHostPros